Get the Stockscreener App
0.2984
110.14%
0.1564
After Hours:
.20
-0.0984
-32.98%
Aclarion Inc stock is traded at $0.2984, with a volume of 299.95M.
It is up +110.14% in the last 24 hours and up +66.70% over the past month.
Aclarion Inc is a healthcare technology company that leverages Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. Its product Nociscan is a SaaS platform that leverages MR Spectroscopy to noninvasively help physicians distinguish between painful and nonpainful discs in the spine. The Company derives its revenues from one source, the delivery of Nociscan reports to medical professionals. Substantially all revenues are generated from contracts with customers in the United States.
See More
Previous Close:
$0.142
Open:
$0.148
24h Volume:
299.95M
Relative Volume:
57.20
Market Cap:
$3.11M
Revenue:
$49,300
Net Income/Loss:
$-6.27M
P/E Ratio:
-0.0328
EPS:
-9.09
Net Cash Flow:
$-5.38M
1W Performance:
+110.73%
1M Performance:
+66.70%
6M Performance:
+1.63%
1Y Performance:
-91.08%
1-Day Range:
$0.1401
$0.3869
1-Week Range:
$0.1286
$0.3869
52-Week Range:
$0.10
$6.75
Aclarion Inc Stock (ACON) Company Profile
Name
Aclarion Inc
Sector
Industry
Phone
833 275 2266
Address
8181 ARISTA PLACE, BROOMFIELD
Compare ACON with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ACON
Aclarion Inc
|
0.2984 | 3.11M | 49,300 | -6.27M | -5.38M | -9.09 |
|
VEEV
Veeva Systems Inc
|
213.03 | 34.59B | 2.66B | 665.91M | 1.08B | 4.05 |
|
SOLV
Solventum Corp
|
67.12 | 11.60B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
55.22 | 10.31B | 516.85M | 174.11M | 217.38M | 0.87 |
|
HQY
Healthequity Inc
|
97.47 | 8.45B | 1.15B | 96.70M | -161.99M | 1.09 |
|
WAY
Waystar Holding Corp
|
36.98 | 6.36B | 906.14M | -52.62M | 89.62M | -0.3621 |
Aclarion Inc Stock (ACON) Latest News
Aclarion, Inc. ends sales agreement with Ascendiant Capital - Investing.com India
Aclarion, Inc. shareholders approve key proposals at annual meeting By Investing.com - Investing.com Nigeria
Breaking News: Aclarion’s Game-Changing Stock Sale! Discover How They're Revolutionizing Back Pain Treatment. - elblog.pl
Aclarion, Inc. ends sales agreement with Ascendiant Capital By Investing.com - Investing.com Nigeria
Aclarion, Inc. shareholders approve key proposals at annual meeting - Investing.com
Aclarion Announces Pricing of Registered Direct Offering of Common Stock Priced at the Market - Yahoo Finance
Aclarion, Inc. Ends Sales Agreement with Ascendiant - TipRanks
Sheridan hospital selected for rural health project - Greenville Daily News
Salesforce (NYSE:CRM) Stock Price Down 1.1% Following Insider Selling - Defense World
Rivian Automotive (NASDAQ:RIVN) Stock Price Down 2.1% on Insider Selling - Defense World
Arch Capital Group Ltd. (NASDAQ:ACGLN) Short Interest Update - Defense World
Red Cat (NASDAQ:RCAT) Trading Down 7.1% Following Insider Selling - Defense World
Enfusion (NYSE:ENFN) Shares Gap Down Following Insider Selling - Defense World
Short Interest in Able View Global Inc. (NASDAQ:ABLV) Grows By 33.6% - Defense World
Progyny (NASDAQ:PGNY) Shares Gap Up After Insider Buying Activity - Defense World
SoundHound AI (NASDAQ:SOUN) Shares Down 1.7% on Insider Selling - Defense World
Aclarion stock hits 52-week low at $0.1 amid sharp annual decline - Investing.com India
Aclarion stock hits 52-week low at $0.1 amid sharp annual decline By Investing.com - Investing.com South Africa
COP29's Green Digital Action Pledge is a clarion call to rethink how we use AI and Big Data - BusinessGreen
Aclarion (ACON) Upgraded to Buy: Here's What You Should Know - Yahoo Finance
Aclarion (NASDAQ:ACON) Earns Hold Rating from Maxim Group - Defense World
Maxim Group Downgrades Aclarion (ACON) - MSN
Aclarion stock hits 52-week low at $0.15 amid sharp annual decline By Investing.com - Investing.com South Africa
Aclarion stock hits 52-week low at $0.15 amid sharp annual decline - Investing.com
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing - AccessWire
Forum Energy Technologies Inc (FET-N) QuotePress Release - The Globe and Mail
Steel Partners (NYSE:SPLP) Shares Gap Down – What’s Next? - Defense World
This bizarre movie about beavers is a clarion call for human creativity in the age of AI - San Francisco Chronicle
Aclarion extends equity line agreement, issues new shares - Investing.com
Aclarion extends equity line agreement, issues new shares By Investing.com - Investing.com Canada
TELUS (TSE:T) Price Target Lowered to C$23.25 at Scotiabank - Defense World
On Constitution Day, Kharge makes a clarion call to bring back ballot papers - Deccan Herald
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash - OrthoSpineNews
Aclarion's Nociscan Pain Detection Platform Featured in Siemens Healthineers Magazine | ACON Stock News - StockTitan
‘We need to fight': Diego Luna's latest a clarion call to protect journalists - Yeni Şafak English
Aclarion, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2024 - Marketscreener.com
Aclarion Inc (ACON) Quarterly 10-Q Report - Quartzy
Aclarion to Present at the Virtual Investor Summit Microcap Event on November 21st - WICZ
Aclarion to Present at Virtual Investor Summit: AI-Driven Back Pain Tech in Focus | ACON Stock News - StockTitan
Agilon Health (AGL) Reports Q3 Loss, Lags Revenue Estimates - MSN
US Stocks Mixed; Core PCE Prices Rise In December - MSN
Sheridan Community Hospital celebrates 80th Anniversary on Nov. 9 - Greenville Daily News
Opinion: Queensland election a clarion call for coal miners - Mining.com.au
Intervertebral Disc Magnetic Resonance Spectroscopy Changes After Spinal Manipulative Therapy for Lumbar Discogenic Pain - Cureus
Sunitha Sarathy’s ‘Had Enough‘ is a clarion call to women to reclaim their position in society - The Hindu
Critical Analysis: MDxHealth (NASDAQ:MDXH) & Aclarion (NASDAQ:ACON) - Defense World
Aclarion’s Nociscan Technology Enhances Understanding of Modic Changes in Back Pain Patients - MSN
Aclarion, Inc. faces Nasdaq delisting over compliance issues By Investing.com - Investing.com Australia
Aclarion, Inc. faces Nasdaq delisting over compliance issues - Investing.com India
Aclarion CEO to Present at 2024 Maxim Healthcare Virtual Summit - Vancity Buzz
Aclarion to Participate in the 2024 Maxim Healthcare Virtual Summit - The Manila Times
Aclarion Inc Stock (ACON) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.26%
0.62%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):